Drug recall · October 26, 2022
Acyclovir Sodium Injection recall
Why: Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Acyclovir Sodium Injection, 500mg/10mL (50mg/mL), 10 mL Single Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520; Made in India, NDC 55150-154-10.
- Lots / codes
Lot: AC22006, Exp 08/2023
- Quantity
- 89400 vials
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide in the USA
- Initiated
- September 26, 2022 · Voluntary: Firm initiated
- Classified
- October 18, 2022
- Reported
- October 26, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Acyclovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.